Polymorph Form II of tanaproget

Details for Australian Patent Application No. 2006241125 (hide)

Owner Wyeth

Inventors Xu, Yan; Ku, Mannching Sherry; Tesconi, Marc Sadler

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006241125

PCT Pub. Number WO2006/116526

Priority 60/675,737 28.04.05 US

Filing date 26 April 2006

Wipo publication date 2 November 2006

Acceptance publication date 5 July 2012

International Classifications

C07D 413/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/536 - ortho- or peri-condensed with carbocyclic ring systems

A61P 5/24 Drugs for disorders of the endocrine system

A61P 15/00 Drugs for genital or sexual disorders

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/116526 Priority application(s): WO2006/116526

5 July 2012 Application Accepted

  Published as AU-B-2006241125

30 August 2012 Alteration of Name

  The name of the applicant has been altered to Wyeth LLC 2007

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006241145-Surface-modified microparticles and methods of forming and using the same

2006241123-Compositions and methods for promoting hemostasis and other physiological activities